This technology is a method for accelerating the maturation of neurons derived from pluripotent stem cells by controlling the expression of RNA splicing factors, particularly Muscleblind Like Splicing Regulator 2 (Mbnl2), enabling better modeling of late-onset neurodegenerative diseases.
